Marcinete Latorre Almeida

Marcinete Latorre Almeida

Auto-generated profile, based on publicly available information

Marcinete Latorre Almeida

Plataforma de Bioensaios de Malária e Leishmaniose (PBML), Fundação Oswaldo Cruz-Rondônia (FIOCRUZ-RO), Porto Velho, RO, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2023 in Current Bioactive Compounds
Verified
Journal Article
Closed access
PDF file
DADinesh Addla
Dinesh Addla
CDCristiane Diniz
Cristiane Diniz
QSQuelli Larissa Oliveira de Santana
Quelli Larissa Oliveira de Santana
LMLeandro Do Nascimento Martinez
Leandro Do Nascimento Martinez
MAMarcinete Latorre Almeida
Marcinete Latorre Almeida
SFSabrina Baptista Baptista Ferreira
Sabrina Baptista Baptista Ferreira
Background: A series of bi-triazoles conjugates 1,2,3 and 1,2,4 was synthesized with an aim to study the evaluation of the antimalarial profile of families of triazole derivatives. The study used the W2 strain of Plasmodium falciparum (Chloroquine-Resistant), to determine the inhibitory concentration of 50% of the parasites (IC50) and HepG2 cells to describe the cytotoxic concentration for 50% of the cells (CC50). Among the study classes, bi-triazoles stood out with IC50 values between 8.9 to 0.45 μM; highlighted the compound 14d (IC50 of 0.45 ± 0.02 μM) with the most promising result. Regarding the cytotoxic concentration, all compounds that presented IC50 values ≤ 100 μM were evaluated. Three compounds stood out as the highest selectivity index (SI) values, 14b (SI ˃111.1), 13d (SI ˃111.1) and 14d (SI ˃1.111). Such results expose the importance of working with classes of molecules that allow rapid synthesis and dispositions for structural changes. Highlighting the evolution of the IC50 values of the compounds, when adding the second triazole block. Thus, the results found in this study, have the possibility of choosing new molecules for the treatment of malaria. Objective: This work was to synthesize a series of bi-triazole conjugates 1,2,3 and 1,2,4-triazole moiety and evaluate their activities against Plasmodium falciparum. Methods: The bi-triazole was synthesized in a 3-step route in moderated yields, and their structures were confirmed by NMR spectral data analyses. For the in vitro antiplasmodial assays, the SYBR Green fluorimetric technique and the W2 strain were used, where an IC50 (Inhibitory Concentration) value was obtained for each compound. The compounds were also evaluated for their stagespecificity and speed of action (W2 strain). Safety tests were performed to determine the hemolytic and cytotoxic action of the evaluated compounds. In these tests, the cell lines HepG2 and VERO were used, and the cytotoxicity was evaluated by the MTT technique. This allowed the CC50 values to be obtained (Cytotoxic Concentration). Subsequently, the Selectivity Index (SI) was calculated for each compound. Results: The newly synthesized bi-triazole compounds could serve as potent leads for the development of novel antimalarial compounds. In general, the bi-triazoles with trifluoromethyl group present at 1,2,4-triazole moiety proved to be more potent regarding antiplasmodial activity. Conclusion: The synthesized bi-triazole compounds could serve as potent leads for the development of novel antimalarial agents.

6 June 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
AJArlindo Gonzaga Branco Junior
Arlindo Gonzaga Branco Junior
ÍSÍtalo Diógenes Gomes da Silva
Ítalo Diógenes Gomes da Silva
SFSaara Neri Fialho
Saara Neri Fialho
MAMarcinete Latorre Almeida
Marcinete Latorre Almeida
LMLeandro Do Nascimento Martinez
Leandro Do Nascimento Martinez
CTCarolina Bioni Garcia Teles
Carolina Bioni Garcia Teles
Objective: To carry out a review of studies published between 2016 and 2021 focusing on the treatment of Leishmaniasis with the drugs Artesunate and Chloroquine. Methods: This is an integrative literature review that was produced using the following steps: identification of the theme, formulation of the guiding question, definition of descriptors and selection of databases, establishment of exclusion and inclusion criteria of the studies, sampling of the literature and pre-selection of articles (reading of abstracts and titles); reading of the selected studies and, finally, interpretation of the results. Results: 134 studies were found for the drug Artesunate, 2 of which were included in this research and show the effectiveness of treatment with Artesunate in in vitro experiments against the species Leishmania amazonensis, L. tropica, L. infantum and L. donovani, as well as in in vivo assays against L. amazonensis. For the drug Chloroquine, 11 articles were found, 3 of which were included in the present study. Of these, two studies evaluated the action of this drug in human trials through intralesional and oral administration, and one evaluated its activity in vitro and in vivo against L. amazonensis. Final considerations: This article highlights studies that present Artesunate and Chloroquine as promising drugs for the treatment of Leishmaniasis. The low number of studies suggests the need for further investigations with in vivo tests and new forms of treatment (topical use) for the lesions.

21 July 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
MSMinelly Azevedo da Silva
Minelly Azevedo da Silva
LMLeandro Do Nascimento Martinez
Leandro Do Nascimento Martinez
MAMarcinete Latorre Almeida
Marcinete Latorre Almeida
AFAmália dos Santos Ferreira
Amália dos Santos Ferreira
SFSaara Neri Fialho
Saara Neri Fialho
CTCarolina Bioni Garcia Teles
Carolina Bioni Garcia Teles
Objective: To evaluate the activity of these compounds on sexual forms of Plasmodium falciparum and to determine the theoretical pharmacokinetic properties of the compounds using in silico assays. Methods: In order to evaluate the inhibition of exflagellant forms, Plasmodium falciparum strain NF54 was used for the production of gametocytes in vitro. The program ADMETlab was used in in silico tests to identify the theoretical pharmacokinetic properties of all compounds. Results: A number of tested natural and synthetic amides do not stand out as possible blockers of malaria transmission. However, they showed moderate inhibition in blocking exflagellation. The results of the virtual screening allowed to know and explore interesting theoretical pharmacokinetic properties of this class of compounds, such as moderate permeability with Caco-2 cells of compound 14f; all can be harmful but non-lethal (LD50); only compound 14f can cause damage to some food (LHID); compounds 1a, 1b, 1g and 1k can be administered at their daily maximum, always noting, 1g and 1k can be administered at their daily maximum; low throughput (CL); high plasma protein binding for compounds 1a, 14f and 18a; optimal distribution volume for 1b, 1g, 1k, 18a and 18b. Final considerations: The results obtained contribute to expand the database on the profile of this class of compounds and antimalarial action.

28 September 2026 in Parasitology International
Verified
Journal Article
Open access
MAMarcinete Latorre Almeida
Marcinete Latorre Almeida
LMLeandro Do Nascimento Martinez
Leandro Do Nascimento Martinez
WNWelington da Silva Paula Do Nascimento
Welington da Silva Paula Do Nascimento
AFAmália dos Santos Ferreira
Amália dos Santos Ferreira
GPGuilherme Matos Passarini
Guilherme Matos Passarini
CTCarolina Bioni Garcia Teles
Carolina Bioni Garcia Teles